TY - JOUR
T1 - Endothelial cell targeting by crgd-functionalized polymeric nanoparticles under static and flow conditions
AU - Martínez-Jothar, Lucía
AU - Barendrecht, Arjan D.
AU - de Graaff, Anko M.
AU - Oliveira, Sabrina
AU - van Nostrum, Cornelus F.
AU - Schiffelers, Raymond M.
AU - Hennink, Wim E.
AU - Fens, Marcel H.A.M.
N1 - Funding Information:
Funding: This research was partially (L.M.-J.) funded by the Consejo Nacional de Ciencia y Tecnología (CONACyT), México, grant number 384743.
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/7/10
Y1 - 2020/7/10
N2 - Since αvβ3 integrin is a key component of angiogenesis in health and disease, Arg-Gly-Asp (RGD) peptide-functionalized nanocarriers have been investigated as vehicles for targeted delivery of drugs to the αvβ3 integrin-overexpressing neovasculature of tumors. In this work, PEGylated nanoparticles (NPs) based on poly(lactic-co-glycolic acid) (PLGA) functionalized with cyclic-RGD (cRGD), were evaluated as nanocarriers for the targeting of angiogenic endothelium. For this purpose, NPs (~300 nm) functionalized with cRGD with different surface densities were prepared by maleimide-thiol chemistry and their interactions with human umbilical vein endothelial cells (HUVECs) were evaluated under different conditions using flow cytometry and microscopy. The cell association of cRGD-NPs under static conditions was time-, concentration-and cRGD density-dependent. The interactions between HUVECs and cRGD-NPs dispersed in cell culture medium under flow conditions were also time-and cRGD density-dependent. When washed red blood cells (RBCs) were added to the medium, a 3 to 8-fold increase in NPs association to HUVECs was observed. Moreover, experiments conducted under flow in the presence of RBC at physiologic hematocrit and shear rate, are a step forward in the prediction of in vivo cell–particle association. This approach has the potential to assist development and high-throughput screening of new endothelium-targeted nanocarriers.
AB - Since αvβ3 integrin is a key component of angiogenesis in health and disease, Arg-Gly-Asp (RGD) peptide-functionalized nanocarriers have been investigated as vehicles for targeted delivery of drugs to the αvβ3 integrin-overexpressing neovasculature of tumors. In this work, PEGylated nanoparticles (NPs) based on poly(lactic-co-glycolic acid) (PLGA) functionalized with cyclic-RGD (cRGD), were evaluated as nanocarriers for the targeting of angiogenic endothelium. For this purpose, NPs (~300 nm) functionalized with cRGD with different surface densities were prepared by maleimide-thiol chemistry and their interactions with human umbilical vein endothelial cells (HUVECs) were evaluated under different conditions using flow cytometry and microscopy. The cell association of cRGD-NPs under static conditions was time-, concentration-and cRGD density-dependent. The interactions between HUVECs and cRGD-NPs dispersed in cell culture medium under flow conditions were also time-and cRGD density-dependent. When washed red blood cells (RBCs) were added to the medium, a 3 to 8-fold increase in NPs association to HUVECs was observed. Moreover, experiments conducted under flow in the presence of RBC at physiologic hematocrit and shear rate, are a step forward in the prediction of in vivo cell–particle association. This approach has the potential to assist development and high-throughput screening of new endothelium-targeted nanocarriers.
KW - nanoparticles
KW - endothelial cells
KW - RGD
KW - targeting
KW - physiological flow
KW - PLGA
UR - http://www.scopus.com/inward/record.url?scp=85087802408&partnerID=8YFLogxK
U2 - 10.3390/nano10071353
DO - 10.3390/nano10071353
M3 - Article
C2 - 32664364
SN - 2079-4991
VL - 10
SP - 1
EP - 19
JO - Nanomaterials
JF - Nanomaterials
IS - 7
M1 - 1353
ER -